Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03450980 · ClinicalTrials.gov registry record

Mobile Medical Application for Cost-effective Strabismus Screening

A clinical trial of Strabismus, sponsored by Massachusetts Eye and Ear Infirmary.

Completed
Registry status
91
Enrollment target
1
Study location

NCT03450980 is a study of Strabismus that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 91 participants, below the 721-participant average among 9 other Strabismus trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03450980, a study of Strabismus, has completed, sponsored by Massachusetts Eye and Ear Infirmary.

COMPLETED
Registry status
91 participants
Enrollment target
1
Study location

Study Summary

Develop and evaluate a new smartphone based app to screen for and measure eye misalignment (strabismus). The investigators will validate the app against simulated strabismus of known magnitude and common clinical tests. They will evaluate the app as a screening tool in high risk populations, to determine the sensitivity and specificity. They hypothesize that the app can measure to within 2 units (prism diopters) of the ground truth, and that it will be correlated with gold standard tests.

Conditions Studied

Study Locations (1)

Massachusetts

  • Ophthalmology of Clinical Research Office, Mass Eye and Ear - Boston

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2018-02-01
Est. Completion 2025-01-30

What the Registry Record Tells You About NCT03450980

The ClinicalTrials.gov registry entry for NCT03450980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 721-participant average among 9 other Strabismus trials with a reported enrollment target (87% lower). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Strabismus appearing as the primary indexed condition, and to 0 interventions.

NCT03450980 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03450980 about?

NCT03450980 is a clinical study titled "Mobile Medical Application for Cost-effective Strabismus Screening". Develop and evaluate a new smartphone based app to screen for and measure eye misalignment (strabismus). The investigators will validate the app against simulated strabismus of known magnitude and common clinical tests. They will evaluate the app as a screening tool in high risk populations, to dete...

What is the current status of trial NCT03450980?

This trial is currently completed. The enrollment target is 91 participants. The study started on 2018-02-01. Estimated completion is 2025-01-30.

What conditions does trial NCT03450980 study?

This clinical trial studies the following conditions: Strabismus.

Who is sponsoring clinical trial NCT03450980?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03450980 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Strabismus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.